Expressing the sense of the Congress regarding scleroderma.
The source supplies the latest action, but no lifecycle stage.
Latest action (14 Feb 2003): Referred to the Subcommittee on Health.
What this bill does
H.Con.Res. 30, introduced in the House of Representatives in February 2003, is a concurrent resolution expressing the sense of Congress regarding scleroderma. The resolution acknowledges that scleroderma is a serious autoimmune disease affecting over 300,000 Americans, primarily women, and that it can cause significant physical hardship, difficulty in diagnosis, and substantial costs.
The resolution calls for increased awareness of scleroderma's symptoms among the public and medical community. It also outlines a role for the Federal Government in promoting awareness, funding research, and considering ways to improve healthcare for patients, including prescription medication affordability. The National Institutes of Health is encouraged to lead research efforts by collaborating with private organizations, funding projects, holding symposia, and conducting various types of research, while the Centers for Disease Control and Prevention is urged to consider a national study to track the disease's incidence.
This resolution was introduced by Representative Luis V. Gutierrez and co-sponsored by other members. After its introduction, it was referred to the House Committee on Energy and Commerce and subsequently to the Subcommittee on Health. As a concurrent resolution, it expresses the opinion of both the House and the Senate but does not require the President's signature to become law.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Official summary
Calls for: (1) recognition of private organizations and health care providers for promoting awareness of and research on scleroderma; (2) greater awareness of the symptoms of scleroderma and contributions to the fight against it; (3) the Government to promote awareness, to adequately fund scleroderma research projects, and to continue to consider ways to improve the quality of health care services for scleroderma patients; (4) the National Institutes of Health to continue to play a leadership role in the fight against scleroderma; and (5) the Centers for Disease Control and Prevention to give priority to establishing a national epidemiological study to better track and gather information about scleroderma.
Timeline
14 Feb 2003
Referred to the Subcommittee on Health.
Common questions
- What does H.Con.Res. 30 do?
- H.Con.Res. 30, introduced in the House of Representatives in February 2003, is a concurrent resolution expressing the sense of Congress regarding scleroderma. The resolution acknowledges that scleroderma is a serious autoimmune disease affecting over 300,000 Americans, primarily women, and that it can cause significant physical hardship, difficulty in diagnosis, and substantial costs. The resolution calls for increased awareness of scleroderma's symptoms among the public and medical community. It also outlines a role for the Federal Government in promoting awareness, funding research, and considering ways to improve healthcare for patients, including prescription medication affordability. The National Institutes of Health is encouraged to lead research efforts by collaborating with private organizations, funding projects, holding symposia, and conducting various types of research, while the Centers for Disease Control and Prevention is urged to consider a national study to track the disease's incidence. This resolution was introduced by Representative Luis V. Gutierrez and co-sponsored by other members. After its introduction, it was referred to the House Committee on Energy and Commerce and subsequently to the Subcommittee on Health. As a concurrent resolution, it expresses the opinion of both the House and the Senate but does not require the President's signature to become law.
- Has H.Con.Res. 30 become law?
- The source does not supply a confirmed lifecycle stage for H.Con.Res. 30. Check the latest action and official source below.
- Who sponsored H.Con.Res. 30?
- H.Con.Res. 30 was sponsored by Rep. Gutierrez, Luis V. [D-IL-4] (D-IL), with 106 cosponsors.
- What's the latest action on H.Con.Res. 30?
- Referred to the Subcommittee on Health. (14 Feb 2003).
Related bills in Health
Choices for Increased Mobility Act of 2026
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Access to Medical Supplies Act
Lower Premiums, Faster Payments Act
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.